HomeBCAX • NASDAQ
Bicara Therapeutics Inc
add
$11.06
0.82%
After Hours:(0.00%)0.00
$11.06
Closed: Sep 18, 5:40:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.02M | 62.12% |
Net income | -27.39M | -60.64% |
Net profit margin | — | — |
Earnings per share | -0.50 | — |
EBITDA | -32.00M | -62.13% |
Effective tax rate | -0.19% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 436.61M | 114.17% |
Total assets | 453.59M | 117.25% |
Total liabilities | 18.39M | 12.95% |
Total equity | 435.20M | — |
Shares outstanding | 54.56M | — |
Price to book | 1.37 | — |
Return on assets | -17.18% | — |
Return on capital | -17.85% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -27.39M | -60.64% |
Cash from operations | -25.59M | -98.28% |
Cash from investing | — | — |
Cash from financing | 135.00K | -81.61% |
Net change in cash | -25.46M | -108.80% |
Free cash flow | -17.97M | — |
Previous close
$10.97
Day range
$10.93 - $11.26
Year range
$7.80 - $28.08
Market cap
603.47M USD
Avg Volume
280.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Headquarters
Website
Employees
55
